Abstract--1. Previous studies have demonstrated the presence of glutathione S-transferases in the skin of rodents and humans. This study represents the first attempt to purify cytosolic glutathione S-transferases from skin of 3-day-old rats.
INTRODUCTION
GSHTr (EC2.5.1.18) represent a family of highly versatile enzymes which are active in catalyzing the conjugation of GSH with a large number of endogenous and exogenous chemicals bearing an electrophilic center (Chasseaud, 1979; Jakoby and Habig, 1980) . GSHTr occur in multiple forms in most tissues and several reports on the purification and characterization of GSHTr isozymes from major organs are available (Jakoby and Habig, 1980; Mannervik, 1985) . In contrast to this, very little is known about GSHTr from skin. Earlier reports have shown the presence of GSHTr activity in rodent skin cells grown in culture (Coomes et al., 1983; Kawashima et al., 1984) and in skin cytosol (Hayakawa et al., 1974; Mukhtar and Bresnick, 1976; Bickers, 1981, 1983; Mukhtar et al., 1981a) . Human skin has also been shown to possess GSHTr activity (Mukhtar and Bresnick, 1976; Mukhtar et al., 1981b) . A brief report based on qualitative immunochemical analysis suggested the presence of multiple forms of cutaneous GSHTr in adult rat (Redick et al., 1982) . It is noteworthy that all the previous studies were performed with crude preparations of cutaneous GSHTr. In this communication, we report for the first time the isolation and partial purification of two groups of GSHTr from skin cytosol of neonatal rats using affinity chromatography and HPLC and some biochemical properties of the major form.
*To whom correspondence should be addressed. Abbreviations: CDNB, 1-chloro-2,4-dinitrobenzene; GSH, reduced glutathione; DTT, dithiothreitol; HPLC, high performance liquid chromatography; GSHTr, glutathione S-transferase(s).
MATERIALS AND METHODS

Materials
CDNB and 1,2-naphthoquinone were purchased from Aldrich Co., Wisconsin, USA. GSH and DTT were obtained from U.S. Biochemical Co. The Sepharose 4B, and 17/~-estradiol-3-sulfate were the products of Sigma Chemical Co. Triphenyltin chloride was from Alfa Products, USA.
Animals
Three day old neonates of inbred CFN rats were used.
Enzyme isolation
Rats were killed by cervical dislocation. The skins were removed and immediately placed in ice-cold 50 mM Tris-HC1 buffer, pH 7.2 containing 0.25 M sucrose (Buffer-A). Each skin was spread epidermal side down on a petridish and the dermis was cleared of fat and muscle by careful scraping with a blunt scalpel. The skins (from 25-30 rats/preparation) were weighed, minced and homogenized in ice-cold buffer-A (20% homogenate, w/v) using an UltraTurrax tissue homogenizer (six 20 sec bursts with 40 sec intervals for cooling). The homogenates were sonicated for 10 sec, rehomogenized in a glass-Teflon homogenizer, and centrifuged at 39,000g for 30 min at 4°C. the supernatant (cytosol) was carefully decanted and used as the enzyme source.
Affinity chromatography
In a typical experiment, cytosol containing about 7 U of GSHTr was applied to the column (2.8 × 6.0 cm) of GSH coupled epoxy-activated Sepharose4B, which was preequilibrated with 50 mM Tris-HCl buffer, pH 7.4 at 4°C. The affinity chromatography of cutaneous GSHTr was conducted as described previously (Radulovic and Kulkarni, 1985) .
High performance liquid chromatography
HPLC was performed as described previously (Radulovic and Kulkarni, 1985) with some modifications. The mobile phase consisted of 10mM potassium phosphate buffer containing 1.0mM DTT and 10mM GSH, pH7.2 (buffer-B), and buffer-C containing 0.4 M KC1 in buffer-B. Prior to HPLC, the eluate from the affinity column was concentrated by ultrafiltration using PM-10 membrane, and dialyzed overnight against buffer-B. An aliquot (0.5-1.0 ml) was injected onto the anion exchange column (Synchrom AX-300 from Synchrom, Linden, IN, USA) and eluted with salt gradient. The program used was as follows: Flow rate of 1.0ml/min and % buffer-C=0 at time (t)=0; % buffer-C was increased to 7.5 in 3min, beginning at t = 5 min; % buffer-C was further increased to 100 in 5 min at t = 8 min; re-equilibration began at t = 21 min, at which time % buffer-C was decreased to 0 over 2 min and the flow was maintained at 2.0ml/min for 15min. The HPLC effluent was collected in 1.0 ml fractions and assayed for GSHTr activity. Those fractions exhibiting GSHTr activity peaks were combined.
Enzyme assay
GSHTr activity toward CDNB was determined at 37°C using an Amino DW-2, as described previously (Radulovic and Kulkarni, 1985) . Duplicate assays were performed with a rate-limiting enzyme concentration. One enzyme unit is defined as the amount of enzyme that causes formation of 1.0/~mole of CDNB-conjugate/min/mg protein. In kinetic and inhibition experiments, the pooled fractions from P-I peak were concentrated by ultrafiltration using PM-10 RETENTION TIME (rnin) membrane and dialyzed against I0 mM potassium phosphate buffer, pH 7.2 containing 0.1 mM GSH before use. Inhibitors were incubated with the enzyme in buffer for 3 min at 37°C, prior to the addition of GSH and CDNB. Mercuric chloride was dissolved in deionized water. All other inhibitors were dissolved in 95% ethanol. The reported data are corrected for solvent effects. Protein content of the cytosol was determined by the method of Lowry et al. (1951) , while the dye binding assay of Bradford (1976) was utilized in subsequent purification steps. Table 1 summarizes the results of the experiments on the purification of GSHTr from skin cytosol of 3-day-old rats using the two-step procedure. GSHTr adsorbed on the affinity matrix eluted as a single peak (not shown) with an average recovery of about 85%. The affinity chromatography step alone resulted in a 615-fold purification of the enzyme. The GSHTr isozymes present in the 4B-GSH concentrate were resolved into 2 peaks of activity by HPLC. The chromatographic profile of GSHTr elution from the HPLC column observed in a typical experiment is depicted in Fig. 1 . The recovery of GSHTr activity during HPLC step was about 82%. Approximately 80% of the total recovered GSHTr activity was present in the major peak (P-l), with a retention time of 4.8 min. This peak emerged from the column just after the void volume and before the salt gradient. The observed average specific activity of 73 #moles of CDNB-conjugate formed/min/mg protein for P-1 corresponds to an overall purification of 2271-fold (Table 1) . The minor peak (P-2) represented about 10%o of the recovered activity, with a retention time of about 14 min. The remaining 10%o of the recovered activity was distributed in low amounts on the fractions which did not constitute P-1 and P-2.
RESULTS
Three separate enzyme preparations were used to evaluate the kinetic parameters of the cutaneous GSHTr. The GSH concentration was kept constant at 2.5 mM for the determination of Km and Vmax for CDNB; while 1.0 mM CDNB was employed for the evaluation of the same parameters for GSH. The estimated values for the kinetic parameters examined are presented in Table  2 . Representative Lineweaver-Burk plots of the kinetic data (Sample 3, Table 2 ) are shown in Figs 2 and 3. Approximately 2-fold variation in the K,, and up to 5-fold variation in the Vma X values was noted with the enzyme preparations used. Fig. 1 . HPLC chromatographic profile of GSHTr. Chromatography was performed as described in Materials and Methods. Protein content was monitored at 280 nm ( ). Specific activity of GSHTr ( ..... ) is expressed in nmoles of CDNB-conjugate formed/min/ml effluent. All fractions contained a 1.0 ml volume. Experiments were also performed in which the relative ability of selected inhibitors to inactivate cutaneous GSHTr was examined. Several pilot experiments were performed to determine inhibitor mental conditions employed, all the chemical tested caused significant inhibition (p =0.05), as determined statistically by paired-t analysis.
DISCUSSION
Irrespective of the tissue source, overlapping substrate specificity is a known qualitative property of all the isozymes of GSHTr studied thus far. Quantitatively however, marked differences in substrate specificity between GSHTr isozymes do exist in different mammalian tissues (Chasseaud, 1979; Jakoby and Habig, 1980; Mannervik, 1985) . CDNB has been most commonly used to measure tissue GSHTr titers since it serves as a substrate for all the known isozymes of GSHTr (Jakoby and Habig, 1980; Mannervik, 1985) . In view of this, the previously reported data based on arene oxides as substrates (Mukhtar and Bresnick, 1976; Bickers, 1981, 1983; Mukhtar et al., 1981a) possibly reflect on a partial quantitation of GSHTr activity in the cytosolic fractions of neonatal rat skin. This is the first communication reporting the GSHTr activity towards CDNB in the cytosol isolated from neonatal rat skin (Table 1) .
Although affinity chromatography yielded substantial purification of cutaneous GSHTr (Table 1) , the observed recovery of enzyme in this step (about 85%) is much lower than that reported for the human placental GSHTr (Radulovic and Kulkarni, 1985) and this may not be related to the denaturation of the enzyme during chromatography. We believe that the observed incomplete recovery of rat cutaneous GSHTr may be due to the loss of certain isozyme(s) of GSHTr that are not bound to the affinity matrix used. It should be noted that this is not a unique property of the cutaneous GSHTr, since similar results, for at least one form (isozyme 5-5) of rat liver GSHTr, have previously been reported (Robertson et al., 1985) .
Similar to the procedure for purification of human placental GSHTr (Radulovic and Kulkarni, 1985) , HPLC was found to be a rapid, and effective method of purification of the cutaneous GSHTr. It was possible to resolve the mixture of GSHTr isozymes, isolated by the affinity chromatography, into at least two groups. The chromatographic behaviour suggests that the GSHTrs present in P-2 stongly interact with the column matrix and may be anionic in nature. By the same token, the apparent minimal interaction with the column matrix noted with the GSHTr eluted in P-1 is indicative of either a basic or neutral nature. In the GSHTr activity profiile (Fig. 1) , a splitting of the P-I peak was observed in all the samples analyzed. This suggests that more than one isozyme of GSHTr may be present in P-I. The kinetic data (Table 2 ) exhibited a wide variation in the results obtained with different enzyme preparations used and this variation, in part, may be due to differences in the ratios of different isozymes present in the P-1 fraction. The K,~ and Vma x values (Table 2 ) and inhibition data for cutaneous GSHTr are, however, within the range reported for purified GSHTr isozymes from several other tissues (Henry and Byington, 1976; Ohl and Litwack, 1977; Kulkarni et al., 1978; Dierickx, 1982; Mannervik, 1985) . In summary, the results indicate that multiple forms of GSHTr exist in the skin cytosol on neonate rats. Although this contention is further supported by an earlier report demonstrating the presence of isozyme B, C and E in adult rat skin by an immunohistochemical technique (Redick et al., 1982) , further studies are needed to clearly resolve this issue.
SUMMARY
Affinity chromatography and HPLC were employed to evaluate the multiplicity of GSHTr in the skin cytosol from 3-day-old rats of CFN strain. The mixture of GSHTr isozymes was resolved into two groups. The major group (isolated as P-I peak by HPLC) represents about 80% of the recovered GSHTr activity and appears to be a composite of neutral and/or basic proteins. Kinetic parameters and relative inhibition by the selected chemicals of P-1 GSHTr were evalutated. Strongly anionic form(s) of GSHTr (P-2) also occur in the skin cytosol but in small amounts. Although the number of isozymes present was not determined, the results, in general, suggest multiplicity of GSHTr in the neonatal rat skin.
